Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113078825> ?p ?o ?g. }
- W3113078825 endingPage "831" @default.
- W3113078825 startingPage "822" @default.
- W3113078825 abstract "Aim To assess the efficacy and safety of glucose-lowering drugs used as adjunct to insulin therapy in adults with type 1 diabetes. Methods We searched Medline, Embase, and the Cochrane Central Register of Controlled Trials up to January 24, 2020 for randomised controlled trials. Our primary outcome was change in HbA1c . We additionally assessed 8 efficacy and 6 safety secondary endpoints. We performed random-effects frequentist network meta-analysis to estimate mean differences (MDs) and odds ratios (ORs), alongside 95% confidence intervals (CIs). We assessed risk of bias and evaluated confidence in the evidence for the primary outcome. Results We included 58 trials comprising 13 216 participants. Overall, sodium-glucose co-transporter (SGLT) inhibitors, liraglutide, glibenclamide, acarbose and metformin reduced HbA1c compared with placebo (MDs ranging from -0.46% [95% CI -0.64 to -0.29] for empagliflozin to -0.20% [-0.35 to -0.06] for metformin). SGLT inhibitors, exenatide daily, liraglutide, and metformin reduced body weight and total daily insulin dose, while liraglutide and SGLT inhibitors reduced blood pressure. Diabetic ketoacidosis and genital infections were more frequent with SGLT inhibitors, while exenatide, liraglutide, pramlintide and metformin increased odds of nausea. No drug increased odds of severe hypoglycaemia. Confidence in evidence was mainly moderate to very low. Conclusions Specific drugs may improve glycaemic control and reduce body weight, blood pressure and total daily insulin dose in patients with type 1 diabetes. However low quality of evidence and increased risk of diabetic ketoacidosis, genital infections or gastrointestinal adverse events should be taken into consideration by healthcare providers and patients. Future long-term trials are needed to clarify their benefit-to-risk profile and elucidate their role in clinical practice. This article is protected by copyright. All rights reserved." @default.
- W3113078825 created "2020-12-21" @default.
- W3113078825 creator A5010856150 @default.
- W3113078825 creator A5011127007 @default.
- W3113078825 creator A5018882870 @default.
- W3113078825 creator A5026527950 @default.
- W3113078825 creator A5045350736 @default.
- W3113078825 creator A5064268470 @default.
- W3113078825 creator A5070546163 @default.
- W3113078825 creator A5084182369 @default.
- W3113078825 creator A5090995179 @default.
- W3113078825 date "2021-01-06" @default.
- W3113078825 modified "2023-10-16" @default.
- W3113078825 title "Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis" @default.
- W3113078825 cites W1495967812 @default.
- W3113078825 cites W1617328014 @default.
- W3113078825 cites W2075046475 @default.
- W3113078825 cites W2085803274 @default.
- W3113078825 cites W2098570086 @default.
- W3113078825 cites W2111999709 @default.
- W3113078825 cites W2121796373 @default.
- W3113078825 cites W2129821518 @default.
- W3113078825 cites W2130235475 @default.
- W3113078825 cites W2131701504 @default.
- W3113078825 cites W2144625636 @default.
- W3113078825 cites W2294791512 @default.
- W3113078825 cites W2496836908 @default.
- W3113078825 cites W2514658869 @default.
- W3113078825 cites W2624031057 @default.
- W3113078825 cites W2769264260 @default.
- W3113078825 cites W2894624538 @default.
- W3113078825 cites W2901511101 @default.
- W3113078825 cites W2911315907 @default.
- W3113078825 cites W2913123058 @default.
- W3113078825 cites W2925030076 @default.
- W3113078825 cites W2935716280 @default.
- W3113078825 cites W2939928664 @default.
- W3113078825 cites W2970684805 @default.
- W3113078825 cites W2971312837 @default.
- W3113078825 cites W2971381958 @default.
- W3113078825 cites W2972869264 @default.
- W3113078825 cites W2984542815 @default.
- W3113078825 cites W2992243344 @default.
- W3113078825 cites W3001442615 @default.
- W3113078825 cites W3008528793 @default.
- W3113078825 cites W3009247057 @default.
- W3113078825 cites W3015163167 @default.
- W3113078825 cites W3018075066 @default.
- W3113078825 doi "https://doi.org/10.1111/dom.14291" @default.
- W3113078825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33300282" @default.
- W3113078825 hasPublicationYear "2021" @default.
- W3113078825 type Work @default.
- W3113078825 sameAs 3113078825 @default.
- W3113078825 citedByCount "15" @default.
- W3113078825 countsByYear W31130788252021 @default.
- W3113078825 countsByYear W31130788252022 @default.
- W3113078825 countsByYear W31130788252023 @default.
- W3113078825 crossrefType "journal-article" @default.
- W3113078825 hasAuthorship W3113078825A5010856150 @default.
- W3113078825 hasAuthorship W3113078825A5011127007 @default.
- W3113078825 hasAuthorship W3113078825A5018882870 @default.
- W3113078825 hasAuthorship W3113078825A5026527950 @default.
- W3113078825 hasAuthorship W3113078825A5045350736 @default.
- W3113078825 hasAuthorship W3113078825A5064268470 @default.
- W3113078825 hasAuthorship W3113078825A5070546163 @default.
- W3113078825 hasAuthorship W3113078825A5084182369 @default.
- W3113078825 hasAuthorship W3113078825A5090995179 @default.
- W3113078825 hasConcept C126322002 @default.
- W3113078825 hasConcept C134018914 @default.
- W3113078825 hasConcept C177713679 @default.
- W3113078825 hasConcept C2777180221 @default.
- W3113078825 hasConcept C555293320 @default.
- W3113078825 hasConcept C71924100 @default.
- W3113078825 hasConcept C95190672 @default.
- W3113078825 hasConceptScore W3113078825C126322002 @default.
- W3113078825 hasConceptScore W3113078825C134018914 @default.
- W3113078825 hasConceptScore W3113078825C177713679 @default.
- W3113078825 hasConceptScore W3113078825C2777180221 @default.
- W3113078825 hasConceptScore W3113078825C555293320 @default.
- W3113078825 hasConceptScore W3113078825C71924100 @default.
- W3113078825 hasConceptScore W3113078825C95190672 @default.
- W3113078825 hasIssue "3" @default.
- W3113078825 hasLocation W31130788251 @default.
- W3113078825 hasOpenAccess W3113078825 @default.
- W3113078825 hasPrimaryLocation W31130788251 @default.
- W3113078825 hasRelatedWork W1563850031 @default.
- W3113078825 hasRelatedWork W2032287785 @default.
- W3113078825 hasRelatedWork W2094113608 @default.
- W3113078825 hasRelatedWork W2167444163 @default.
- W3113078825 hasRelatedWork W2233866314 @default.
- W3113078825 hasRelatedWork W2383009242 @default.
- W3113078825 hasRelatedWork W2415759662 @default.
- W3113078825 hasRelatedWork W3036934084 @default.
- W3113078825 hasRelatedWork W2903040050 @default.
- W3113078825 hasRelatedWork W88627568 @default.
- W3113078825 hasVolume "23" @default.
- W3113078825 isParatext "false" @default.
- W3113078825 isRetracted "false" @default.